Torre Lazur wins AOR for Entereg

Torre Lazur McCann Healthcare Group was named AOR for Entereg—the first and only FDA-approved agent indicated to accelerate the time to upper and lower GI recovery following partial large or small bowel resection surgery with primary anastomosis—and will re-launch the brand for GlaxoSmithKline and Adolor.

Meanwhile, its sister agency, Torre Lazur McCann London, won the global launch for a new contraceptive by Bayer Schering Pharma, plus the re-launch across Europe of Invega for schizophrenia, an atypical antipsychotic that helps treat both the “positive” and the “negative” symptoms of schizophrenia.


Next Article in Features

The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.